Biotech and Pharmaceuticals Medicine

  • CVS Health will open "hundreds" of SmileDirectClub locations inside its stores this year, with plans to open more than 1,000 locations over the next two years, the drugstore chain announced Thursday.

  • New York City Mayor Bill de Blasio speaks during a news conference declaring a public health emergency in parts of Brooklyn in response to a measles outbreak, requiring unvaccinated people living in the affected areas to get the vaccine or face fines, in the Orthodox Jewish community of the Williamsburg neighborhood, in Brooklyn, New York City, April 9, 2019.

    As of Wednesday afternoon, 695 cases of measles were confirmed in 22 states, the CDC announced, surpassing the previous high of 667 cases for all of 2014.

  • On Tuesday, the government charged drug distributor Rochester Drug Co-operative Inc and company executives for their role in fueling the epidemic. Deaths from opioid overdose in the United States jumped 17 percent in 2017 from a year earlier to more than 49,000 according to the Centers for Disease Control and Prevention. China last month listed all...

  • Lilly in November received the U.S. Food and Drug Administration's "breakthrough" status for its migraine drug Emgality in treating episodic cluster headaches. Teva's decision could be positive for Lilly's drug in differentiating it from its rivals, BMO Capital Markets analyst Alex Arfaei said. Israel- based Teva, the world's largest generic drugmaker, is...

  • Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, April 25, 2017.

    In rare public comments on behalf of the family that controls Purdue Pharma, lawyer Mary Jo White said why the family believed the litigation against them and their company is legally dubious, factually misleading and politically motivated.

  • April 23- Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches. Lilly in November received the U.S. Food and Drug Administration's "breakthrough" status for its migraine drug in treating episodic cluster headaches. Israel- based Teva, the world's largest generic drugmaker, is...

  • FDA SAYS HAS DETERMINED THAT MEASLES, MUMPS AND RUBELLA VACCINE IS BOTH SAFE AND EFFECTIVE IN PREVENTING THESE DISEASES.

  • The U.S. Centers for Disease Control and Prevention said it had recorded 626 cases of the highly contagious and sometimes deadly disease in 22 states as of April 19, the highest rate of infection in five years. Iowa and Tennessee were the two states that joined the CDC list with new measles cases. More than half the cases recorded this year occurred in New York City,...

  • Political risk is coming into focus: Amundi Pioneer

    John Carey of Amundi Pioneer says "sharp declines" in health care stocks were likely related to political debates in the U.S.

  • A customer views merchandise for sale at a Walgreens store in the Hollywood neighborhood of Los Angeles.

    Two of the most important terms in health insurance are premiums and deductibles. Here's what they mean and how you should think about them as part of your health-care costs.

  • TORONTO, April 16- Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada. Only about 100 people in Canada have the disease, but at list prices Procysbi costs C $325,000 per year, according to...

  • Customers move a cart full of water through a BJ's Wholesale Club Inc. store in Falls Church, Virginia.

    One of the first randomized clinical studies of a corporate wellness program tracking 30,000 workers reveals companies may need to temper expectations on better health outcomes and lower health-care spending. There's still more promise than payoff.

  • April 15- The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent in the week ended April 11, in the country's second-worst outbreak in nearly two decades, federal health officials reported on Monday. As of April 11, the U.S. Centers for Disease Control and Prevention recorded 555 cases of the disease since the beginning...

  • April 15- Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12- month course of injections. The U.S. Food and Drug Administration last week approved bone-building Evenity for postmenopausal women who are at high risk of fracture, but required the label to have a boxed warning, the FDAs strictest,...

  • April 15- The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent in the week ended April 11 in the country's second-worst outbreak in nearly two decades, federal health officials reported on Monday. As of April 11, the U.S. Centers for Disease Control and Prevention recorded 555 cases of the disease since the beginning...

  • April 15- The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent in the week ended April 11 in the country's second-worst outbreak in nearly two decades, federal health officials reported on Monday. New York City has recorded at least 285 cases of measles since October, according to local health officials, the large...

  • Ground beef exits a grinder.

    The agency said it is looking at the grocery stores and restaurants where people said they ate beef just before they fell ill to try to find the source.

  • In vitro fertilisation (IVF) being performed by a fertility doctor (right).

    Fertility doctors in Greece and Spain say they made medical history after a healthy baby boy was born using genetic information from three parents.

  • A box of Indivior's Suboxone medication sits on a pharmacy shelf in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.

    Shares of Indivior sank 44 percent on Wednesday after the U.S. Justice Department indictment for illegal marketing.

  • April 9- The U.S. Food and Drug Administration said on Tuesday it had approved Amgen Inc's osteoporosis treatment for postmenopausal women who are at high risk of fracture. Evenity comes with a boxed warning, the FDA's strictest warning, flagging increased risk of heart attack, stroke and cardiovascular-related death. "It's important to carefully select...